Skip to content
StockMarketAgent
Sector pending / General Medical and Surgical HospitalsUpdated 2026-05-10 22:07 UTC

BOM/532150 stock hub

BOM/532150 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BOM/532150is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
39B
Bombay Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BOM/532150
In the news

Latest news · BOM/532150

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.5
P25 n/aP50 n/aP75 n/a
Trailing P/E21.3
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC73.2
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BOM/532150 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
184
Groups with data
10
Currency
INR
Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
India
Country code
IN
Employees
3,035
Employees Change
58%
Employees Change Percent
1.95
Enterprise value
INR 34.7B
Exchange
Bombay Stock Exchange
Financial currency
INR
First seen
2026-05-10
Industry
General Medical and Surgical Hospitals
Last refreshed
2026-05-10
Market cap
INR 39B
Price
INR 425
Price currency
INR
Rev Per Employee
4,782,372.32x
Sic
8062
Symbol
bom/532150
Website
https://www.apollohospitals.com/delhi/

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
4.69%
EV Earnings
18.96x
EV/EBIT
15.41x
EV/EBITDA
12.76x
EV/Sales
2.39x
Forward P/E
19.52x
P/B ratio
5.92x
P/E ratio
21.31x
P/S ratio
2.69x
PE Ratio10 Y
22.04x
PE Ratio3 Y
18.89x
PE Ratio5 Y
25.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
15.51%
EBITDA Margin
18.46%
Gross margin
60.28%
Gross Profit
INR 8.7B
Gross Profit Growth
13.05%
Gross Profit Growth Q
24.41%
Gross Profit Growth3 Y
16.65%
Gross Profit Growth5 Y
20.89%
Net Income
INR 1.8B
Net Income Growth
21.03%
Net Income Growth Q
24.96%
Net Income Growth3 Y
30.93%
Pretax Margin
16.97%
Profit Margin
12.6%
Profit Per Employee
INR 602,735
Roa5y
11.56
Roe5y
20.76
ROIC
73.23
Roic5y
29.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr10y
25.38%
Cagr15y
21.21%
Cagr1y
11.11%
Cagr20y
16.27%
Cagr3y
73.31%
Cagr5y
38.91%
Div CAGR10
9.6%
Div CAGR3
14.47%
Div CAGR5
12.47%
EPS Growth
20.98
EPS Growth Q
24.86
EPS Growth3 Y
30.97
Revenue Growth
8.53x
Revenue Growth Q
14.37x
Revenue Growth3 Y
11.71x
Revenue Growth5 Y
18.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

13
MetricValue
Cash
INR 4.6B
Debt
INR 313.4M
Debt EBITDA
INR 0.12
Debt Equity
INR 0.05
Equity
INR 6.6B
Interest Coverage
80.95
Net Cash
INR 4.3B
Net Cash By Market Cap
INR 11.03
Net Cash Growth
55.49%
Net Debt EBITDA
INR -1.61
Net Debt Equity
INR -0.65
Tangible Book Value
INR 6.6B
Tangible Book Value Per Share
INR 71.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-0.04%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
INR 4.5
Dividend Years
4
Dividend Yield
1.08%
Ex Div Date
2025-09-18
Last Dividend
INR 4.5
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
859.36%
1Y total return
11.11%
200-day SMA
456.6
3Y total return
420.76%
50-day SMA
405.1
50-day SMA vs 200-day SMA
50under200
5Y total return
417.07%
All Time High
640.1
All Time High Change
-33.54%
All Time High Date
2025-11-06
All Time Low
4.96
All Time Low Change
8,473.16%
All Time Low Date
2001-09-17
ATR
14.7
Ch YTD
-4.99
High
433.9
High52
640.1
High52 Date
2025-11-06
High52ch
-33.54%
Low
416
Low52
342.4
Low52 Date
2026-01-27
Low52ch
24.26%
Ma50ch
5.02%
Price vs 200-day SMA
-6.83%
RSI
57.58
RSI Monthly
53.88
RSI Weekly
49.29
Sharpe ratio
0.32x
Sortino ratio
0.69
Total Return
1.04%
Tr YTD
-4.99
Tr15y
1,690.58%
Tr1m
2.31%
Tr1w
3.07%
Tr3m
12.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
INR 2.3B
Operating Income Growth
19.12
Operating Income Growth Q
23.72
Operating Income Growth3 Y
25.6
Operating margin
15.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
40,987,423%
Shares Insiders
2.9%
Shares Institutions
5.03%
Shares Qo Q
0.14%
Shares Yo Y
0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Average Volume
13,291.3x
Bv Per Share
71.88
Ch10y
676.3
Ch15y
1,081.7
Ch1m
2.31
Ch1w
3.07
Ch1y
10.07
Ch20y
1,002.1
Ch3m
12.78
Ch3y
401.5
Ch5y
381
Ch6m
-31.35
Change
2.26%
Change From Open
2.12
Close
416
Days Gap
0.13
Depreciation Amortization
429,125,000
Dollar Volume
8,816,840.4
Earnings Date
2026-05-12
EBIT
INR 2.3B
EBITDA
INR 2.7B
EPS
INR 19.95
F Score
2
Fiscal Year End
March
Founded
1,983
Graham Number
179.60818
Graham Upside
-57.78
Income Tax
INR 633.5M
Is Primary Listing
0
Last Earnings Date
2026-02-03
Last Report Date
2025-12-31
Lynch Fair Value
INR 499
Lynch Upside
17.3
Ma150
452.8
Ma150ch
-6.05%
Ma20
415.4
Ma20ch
2.41%
Next Earnings Date
2026-05-12
Open
416.6
Payment Date
2025-10-24
Position In Range
52.66
Price Date
2026-05-08
Price EBITDA
INR 14.55
Ptbv Ratio
5.93
Relative Volume
1.56x
Revenue
14,514,500,000x
Tax By Revenue
4.36x
Tax Rate
25.72%
Tr20y
1,937.71%
Tr6m
-31.35%
Volume
20,726
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

BOM/532150 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.1%
$4.50 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+12.5%
0 consecutive years of growth
Total shareholder yield
+1.0%
Next ex-dividend date: 2025-09-18
Performance

BOM/532150 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+11.1%
S&P 500 1Y: n/a
3Y total return
+420.8%
S&P 500 3Y: n/a
5Y total return
+417.1%
S&P 500 5Y: n/a
10Y total return
+859.4%
S&P 500 10Y: n/a
Ownership

Who owns BOM/532150?

Insider, institutional, and short-interest positioning.

Institutional ownership
+5.0%
Share of float held by funds and institutions
Insider ownership
+2.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

BOM/532150 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
57.6
Neutral momentum band
Price vs 200-day MA
-6.8%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.32
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BOM/532150

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/532150 stock rating?

bom/532150 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/532150 analysis?

The full report lives at /stocks/bom/532150/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/532150?

The latest report frames bom/532150 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/532150 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.